crenolanib: Clinical Trials

5 trials of crenolanib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 21Completed 1

Follow crenolanib: new trials by email Literature Review of crenolanib trials Research Report on crenolanib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma
Crenolanib, Ramucirumab, Paclitaxel - Esophagogastric Adenocarcinoma
Phase 1CompletedArog Pharmaceuticals, Inc.302017-04-142020-07-20
Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML
Crenolanib, Mitoxantrone, Cytarabine - Relapsed/Refractory Acute Myeloid Leukemia (AML)
Phase 1 / Phase 2CompletedArog Pharmaceuticals, Inc.162016-02-012023-12-20
Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
Crenolanib, Sorafenib, methotrexate, hydrocortisone and cytarabine with leucovorin - Acute Myeloid Leukemia
Phase 1CompletedSt. Jude Children's Research Hospital102015-04-022017-10-03
PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
Crenolanib - Diffuse Intrinsic Pontine Glioma, Progressive or Refractory High-Grade Glioma
Phase 1CompletedSt. Jude Children's Research Hospital552011-07-012017-04-26
CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors
CP-868,596, Docetaxel, AG-013736 - Advanced Solid Tumors
Phase 1CompletedArog Pharmaceuticals, Inc.502005-12-012012-01-19

Conditions studied

Leukemia, Myeloid, Acute (2)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Glioma (1)

Sponsors

Arog Pharmaceuticals, Inc. (3)  ·  St. Jude Children's Research Hospital (2)

Countries

United States (5)  ·  Australia (1)

Top investigators

Alberto Broniscer, MD (1)  ·  Geoffrey Ku, MD (1)  ·  Hiroto Inaba, MD, PhD (1)

Results publications

PMID 35066693